晶泰科技2025年营收翻三倍：港股迎首家盈利AI4S企业，亦为首家盈利AI应用企业

Core Viewpoint - Jingtai Technology has officially entered the stage of scalable value realization, marking a significant milestone in its growth trajectory as it becomes the first profitable AI application company listed in Hong Kong [5][7]. Financial Performance - In 2025, Jingtai Technology achieved a revenue of 803 million RMB, representing a year-on-year growth of 201.2%. The net profit reached 135 million RMB, with an adjusted net profit of 258 million RMB, indicating its first annual profitability [5]. - As of December 31, 2025, the company had a cash balance of 7.069 billion RMB and a net issuance of convertible bonds amounting to 2.562 billion RMB, providing a solid financial foundation for ongoing R&D investments [6]. Business Development - The number of revenue-generating clients increased by 62% year-on-year, covering 17 of the top 20 global pharmaceutical companies, with cumulative cooperation amounts reaching hundreds of billions of RMB [6]. - Jingtai Technology has empowered and incubated over five first-in-class/best-in-class innovative pipelines, entering clinical and IND-enabling stages across various disease areas, including oncology and chronic diseases [6]. Strategic Upgrades - The AI4S smart solution business saw a revenue increase of 62.6% to 265 million RMB in 2025, reflecting a strategic upgrade from traditional delivery to a comprehensive intelligent R&D system [12]. - The company has transitioned its business model from single project services to a strategy of "platform licensing + joint development + milestone revenue," laying a solid foundation for sustainable growth [13]. Technological Integration - Jingtai Technology's "AI + Robotics + Multi-Agent" system has created a self-evolving R&D model, enhancing efficiency in drug discovery and development [15][19]. - The company has developed over 200 industry-specific AI models, covering the entire chain from target discovery to preclinical candidate screening, supported by a robust data asset system [20]. Cross-Industry Expansion - Jingtai Technology is accelerating the application of its core capabilities into consumer health and new materials sectors, demonstrating the platform's universal value [22]. - In the consumer health sector, the company has registered innovative external molecules for hair growth, achieving significant market recognition [22]. - In the photovoltaic sector, a strategic partnership with Jinko Solar aims to develop AI-driven high-throughput solar cell manufacturing lines, showcasing the company's commitment to next-generation technology [24][25]. Future Outlook - The company plans to deepen the flywheel effect of technological iteration, leveraging its AI models and automated laboratories to maintain its leading position in the AI for Science field while expanding into broader sectors [27].